Anti-SEM7A/ SEMA7A/ CD108 monoclonal antibody

Anti-SEM7A/ SEMA7A/ CD108 antibody for FACS & in-vivo assay

Target products collectionGo to SEMA7A/SEMA7A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1504-Ab-1/ GM-Tg-hg-MP1504-Ab-2Anti-Human SEMA7A monoclonal antibodyHuman
GM-Tg-rg-MP1504-Ab-1/ GM-Tg-rg-MP1504-Ab-2Anti-Rat SEMA7A monoclonal antibodyRat
GM-Tg-mg-MP1504-Ab-1/ GM-Tg-mg-MP1504-Ab-2Anti-Mouse SEMA7A monoclonal antibodyMouse
GM-Tg-cynog-MP1504-Ab-1/ GM-Tg-cynog-MP1504-Ab-2Anti-Cynomolgus/ Rhesus macaque SEMA7A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1504-Ab-1/ GM-Tg-felg-MP1504-Ab-2Anti-Feline SEMA7A monoclonal antibodyFeline
GM-Tg-cang-MP1504-Ab-1/ GM-Tg-cang-MP1504-Ab-2Anti-Canine SEMA7A monoclonal antibodyCanine
GM-Tg-bovg-MP1504-Ab-1/ GM-Tg-bovg-MP1504-Ab-2Anti-Bovine SEMA7A monoclonal antibodyBovine
GM-Tg-equg-MP1504-Ab-1/ GM-Tg-equg-MP1504-Ab-2Anti-Equine SEMA7A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1504-Ab-1/ GM-Tg-hg-MP1504-Ab-2; GM-Tg-rg-MP1504-Ab-1/ GM-Tg-rg-MP1504-Ab-2;
GM-Tg-mg-MP1504-Ab-1/ GM-Tg-mg-MP1504-Ab-2; GM-Tg-cynog-MP1504-Ab-1/ GM-Tg-cynog-MP1504-Ab-2;
GM-Tg-felg-MP1504-Ab-1/ GM-Tg-felg-MP1504-Ab-2; GM-Tg-cang-MP1504-Ab-1/ GM-Tg-cang-MP1504-Ab-2;
GM-Tg-bovg-MP1504-Ab-1/ GM-Tg-bovg-MP1504-Ab-2; GM-Tg-equg-MP1504-Ab-1/ GM-Tg-equg-MP1504-Ab-2
Products NameAnti-SEMA7A monoclonal antibody
Formatmab
Target NameSEMA7A
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SEMA7A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SEM7A/ SEMA7A/ CD108 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP001729human SEMA7A Lentivirus plasmid
    ORF Viral VectorvGMLP001729human SEMA7A Lentivirus particle


    Target information

    Target IDGM-MP1504
    Target NameSEMA7A
    Gene ID8482,20361,315711,702185,487644,101088844,614707,100062559
    Gene Symbol and Synonyms2900057C09Rik,CD108,CDw108,H-Sema K1,H-SEMA-K1,H-Sema-L,JMH,M-Sema-L,PFIC11,sema K1,sema L,SEMA7A,SEMAK1,SEMAL
    Uniprot AccessionO75326
    Uniprot Entry NameSEM7A_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000138623
    Target ClassificationN/A

    The target: SEMA7A, gene name: SEMA7A, also named as CD108, CDw108, H-SEMA-K1, H-Sema-L, JMH, SEMAK1, SEMAL. This gene encodes a member of the semaphorin family of proteins. The encoded preproprotein is proteolytically processed to generate the mature glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein. The encoded protein is found on activated lymphocytes and erythrocytes and may be involved in immunomodulatory and neuronal processes. The encoded protein carries the John Milton Hagen (JMH) blood group antigens. Mutations in this gene may be associated with reduced bone mineral density (BMD). Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.